Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of AZD4144 Alone and With Itraconazole in Healthy Participants
NCT07685600Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of AZD4144 (2 arms), sponsored by AstraZeneca. Primary endpoints: Area under concentration time curve from time 0 to infinity, Area under concentration curve from time 0 to the last quantifiable concentration and 1 more. Started Jul 2026; status: completed.
02
Drugs
AZD4144
Beyond the preview
Go deeper on NCT07685600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07685600.